Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome

Smith GA, Henderson IC . High-dose chemotherapy (HDC) with autologous bone marrow transplantation (ABMT) for the treatment of breast cancer: the jury is still out Imp Adv Oncol 1995 95: 201–214

Antman KH, Rowlings PA, Vaughan WP et al. High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America J Clin Oncol 1997 15: 1870–1879

Deeg J, Socié G . Malignancies after hematopoietic stem cell transplantation: many questions, some answers Blood 1998 91: 1833–1844

Kollmannsberger C, Hartmann JT, Kanz L et al. Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignancies J Cancer Res Clin Oncol 1998 124: 207–214

Darrington DL, Vose JM, Anderson JR et al. Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies J Clin Oncol 1994 12: 2527–2534

Stone RM, Neuberg D, Soiffer R et al. Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma J Clin Oncol 1994 12: 2535–2542

Govindarajan R, Jagannath S, Flick JT et al. Preceding standard therapy is the likely cause of MDS after autotransplants for multiple mieloma Br J Haematol 1996 95: 349–353

Miller JS, Arthur DC, Litz CE et al. Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy Blood 1994 83: 3780–3786

Traweek ST, Slovak ML, Nademanee AP et al. Clonal karyotypic hematopoietic cell abnormalities occurring after autologous bone marrow transplantation for Hodgkin's disease and non-Hodgkin's lymphoma Blood 1994 84: 957–963

Drach J, Ayers D, Govindarajan R et al. MDS-associated cytogenetic abnormalities in both hematopoietic and neoplastic cells after autotransplants in 868 patients with multiple mieloma Blood 1998 92: (Suppl. 1) 97a (Abstr. 398)

van Leeuwen FE . Risk of acute myelogenous leukaemia and myelodysplasia following cancer treatment Baillières Clin Haematol 1996 9: 57–85

Diamandidou E, Buzdar AU, Smith TL et al. Treatment-related leukemia in breast cancer patients treated with fluorouracil-doxorubicin-cyclophosphamide combination adjuvant chemotherapy: the University of Texas MD Anderson Cancer Center experience J Clin Oncol 1996 14: 2722–2730

Roman-Unfer S, Bitran JD, Hanauer S et al. Acute myeloid leukemia and myelodysplasia following intensive chemotherapy for breast cancer Bone Marrow Transplant 1995 16: 163–168

Laughlin MJ, McGaughey DS, Crews JR et al. Secondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant J Clin Oncol 1998 16: 1008–1012

Thirman MJ, Larson RA . Therapy-related myeloid leukemia Hematol Oncol Clin North Am 1996 10: 293–320

Bhatia S, Ramsay NK, Steinbuch M et al. Malignant neoplasms following bone marrow transplantation Blood 1996 87: 3633–3639

Le Beau MM, Albain KS, Larson RA et al. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes 5 and 7 J Clin Oncol 1986 4: 325–345

Insa A, Lluch A, Prosper F et al. High-dose chemotherapy with stem cell transplant in patients with high risk breast cancer: results of a case control study J Clin Oncol (submitted)

An International System for Human Cytogenetic Nomenclature (ISCN). Mitelman F (ed). S Karger: Basel, 1995

Martínez-Climent JA, Thirman MJ, Espinosa III R et al. Detection of 11q23/MLL rearrangements in infant leukemias with fluorescence in situ hybridization and molecular analysis Leukemia 1995 9: 1299–1304

Bennett JM, Catovsky D, Daniel MT et al. Proposal for the classification of the myelodysplastic syndromes Br J Haematol 1982 51: 182–199

Bennett JM, Catovsky D, Daniel MT et al. Proposed revised criteria for the classification of acute myeloid leukemia Ann Intern Med 1985 103: 620–625

Bennett JM, Catovsky D, Daniel MT et al. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO) Br J Haematol 1991 78: 325–329

Wilson CS, Traweek ST, Slovak ML et al. Myelodysplastic syndrome occurring after autologous bone marrow transplantation for lymphoma. Morphologic features Am J Clin Pathol 1997 108: 369–377

Mitelman F, Johansson B, Mertens F . Catalog of Chromosome Aberrations in Cancer 5th edn, Wiley-Liss: New York 1995

Bredeson CN, Barnett MJ, Horsman DE et al. Therapy-related acute myelogenous leukemia associated with 11q23 chromosomal abnormalities and topoisomerase II inhibitors: report of four additional cases and brief commentary Leuk Lymphoma 1993 11: 141–145

Heimdal K, Evensen SA, Fossa SD et al. Karyotyping of a hematologic neoplasia developing shortly after treatment for cerebral extragonadal germ cell tumor Cancer Genet Cytogenet 1991 57: 41–46

Paietta E, Papenhausen P, Gucalp R et al. The 5q− deletion: correlation of breakpoints with the immunophenotype of leukemic blast cells Leukemia 1987 1: 822–824

Roulston D, Anastasi J, Rudinsky R et al. Therapy-related acute leukemia associated with t(11q23) after primary acute myeloid leukemia with t(8;21). A report of two cases Blood 1995 86: 3613–3614

Pedersen-Bjergaard J, Pedersen M, Myhre J et al. High risk of therapy-related leukemia after BEAM chemotherapy and autologous stem cell transplantation for previously treated lymphomas is mainly related to primary chemotherapy and not to the BEAM-transplantation procedure Leukemia 1997 11: 1654–1660

Soligo DA, Lambertenghi Deliliers G, Servida F et al. Haematopoietic abnormalities after autologous stem cell transplantation in lymphoma patients Bone Marrow Transplant 1998 21: 15–22

Perot C, van den Akker J, Laporte JP et al. Multiple chromosome abnormalities in patients with acute leukemia after autologous bone marrow transplantation using total body irradiation and marrow purged with mafosfamide Leukemia 1993 7: 509–515

Testoni N, Martinelli G, Zaccaria A et al. Detection of occasional and clonal chromosome aberrations in patients with acute non-lymphocytic leukemia after autologous bone marrow transplantation Bone Marrow Transplant 1996 18: 1141–1145

Imrie KR, Dube I, Prince HM et al. New clonal karyotypic abnormalities acquired following autologous bone marrow transplantation for acute myeloid leukemia do not appear to confer an adverse prognosis Bone Marrow Transplant 1998 21: 395–399

Abruzzesse E, Radford JE, Miller JS et al. Detection of abnormal pre-transplant clones in progenitor cells of patients who developed myelodysplasia after myeloablative therapy Blood 1997 90: (Suppl. 1) 590a (Abstr. 2625)

Amigo ML, del Canizo MC, Hernandez JM et al. Clonal myelodysplastic cells present in apheresis product before transplantation Leukemia 1998 12: 1497–1499